American Tower (NYSE:AMT) Updates FY 2025 Earnings Guidance

American Tower (NYSE:AMT) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 10.310-10.500 for the period, compared to the consensus earnings per share estimate of 10.460. The company issued revenue guidance of -. American Tower also updated its FY25 guidance to $10.31 to $10.50 EPS.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Mizuho lowered their target price on shares of American Tower from $221.00 to $204.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 8th. Citigroup lowered their price target on American Tower from $255.00 to $220.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Morgan Stanley reduced their price objective on American Tower from $219.00 to $213.00 and set an “equal weight” rating for the company in a report on Monday. Citizens Jmp upgraded American Tower to a “strong-buy” rating in a research report on Monday, January 27th. Finally, StockNews.com lowered American Tower from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, American Tower presently has an average rating of “Moderate Buy” and a consensus price target of $225.21.

American Tower Stock Up 0.6 %

Shares of NYSE AMT traded up $1.16 on Thursday, hitting $201.89. The company had a trading volume of 820,042 shares, compared to its average volume of 2,235,605. The firm has a market capitalization of $94.34 billion, a P/E ratio of 85.18, a PEG ratio of 1.29 and a beta of 0.84. American Tower has a 12-month low of $170.46 and a 12-month high of $243.56. The business has a 50 day moving average of $186.16 and a two-hundred day moving average of $206.96. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 3.27.

American Tower (NYSE:AMT) last announced its earnings results on Tuesday, February 25th. The real estate investment trust reported $2.62 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.83. American Tower had a net margin of 10.05% and a return on equity of 22.01%. The business had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the prior year, the firm earned $2.29 earnings per share. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, equities research analysts forecast that American Tower will post 10.14 earnings per share for the current fiscal year.

American Tower Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Friday, December 27th were paid a $1.62 dividend. This represents a $6.48 annualized dividend and a dividend yield of 3.21%. The ex-dividend date of this dividend was Friday, December 27th. American Tower’s dividend payout ratio (DPR) is 273.42%.

Insider Buying and Selling at American Tower

In other American Tower news, CFO Rodney M. Smith sold 16,567 shares of the stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $181.10, for a total transaction of $3,000,283.70. Following the transaction, the chief financial officer now directly owns 62,792 shares in the company, valued at $11,371,631.20. This represents a 20.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.18% of the stock is owned by insiders.

American Tower Company Profile

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.